doxazosin has been researched along with Prostatitis in 9 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the safety and efficacy of the selective 5-serotonin and norepinephrine reuptake inhibitor duloxetine hydrochloride and alpha-adrenergic receptor blocker (alpha-blocker) doxazosin mesylate-controlled tablets in the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 9.24 | Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study. ( Dong, D; Ji, Z; Li, H; Yan, S; Zhang, M, 2017) |
| "We performed a prospective, randomized study to examine the efficacies of levofloxacin and doxazosin alone and as a combination therapy in patients with National Institutes of Health (NIH) category III chronic prostatitis/chronic pelvic pain syndrome." | 9.13 | Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. ( Jeong, CW; Jeong, H; Lee, SE; Lim, DJ; Son, H, 2008) |
| "The efficacy of doxazosin monotherapy in chronic non-bacterial prostatitis was investigated in terms of urinary symptom, pain and quality of life assessment versus placebo." | 9.10 | Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo. ( Burgut, R; Evliyaoğlu, Y, 2002) |
| "To evaluate the influence of doxazosin and finasteride on histologic findings in benign prostatic hyperplasia accompanied by prostatitis, and to examine the factors related with prostate carcinogenesis." | 7.74 | Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation. ( Park, DS; Shim, JY, 2008) |
| "Doxazosin was given for 30 days, and at the second visit IPSS, NIH-CPSI and IIEF-5 scores, Qmax and PMR were once more analysed." | 5.37 | Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. ( Aktas, A; Eryildirim, B; Faydaci, G; Kuyumcuoglu, U; Tarhan, F; Tuncer, M, 2011) |
| "To explore the safety and efficacy of the selective 5-serotonin and norepinephrine reuptake inhibitor duloxetine hydrochloride and alpha-adrenergic receptor blocker (alpha-blocker) doxazosin mesylate-controlled tablets in the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 5.24 | Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study. ( Dong, D; Ji, Z; Li, H; Yan, S; Zhang, M, 2017) |
| "We performed a prospective, randomized study to examine the efficacies of levofloxacin and doxazosin alone and as a combination therapy in patients with National Institutes of Health (NIH) category III chronic prostatitis/chronic pelvic pain syndrome." | 5.13 | Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. ( Jeong, CW; Jeong, H; Lee, SE; Lim, DJ; Son, H, 2008) |
| "The efficacy of doxazosin monotherapy in chronic non-bacterial prostatitis was investigated in terms of urinary symptom, pain and quality of life assessment versus placebo." | 5.10 | Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo. ( Burgut, R; Evliyaoğlu, Y, 2002) |
| "To evaluate the influence of doxazosin and finasteride on histologic findings in benign prostatic hyperplasia accompanied by prostatitis, and to examine the factors related with prostate carcinogenesis." | 3.74 | Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation. ( Park, DS; Shim, JY, 2008) |
| " The former was treated by applying the CRS-2280E extraorgan short-wave capacitance field hyperthermia system to the prostate once an hour every other day for 7 times, combined with anal administration of 1 Qianliean suppository and oral doxazosin 4 mg before bedtime every night for 2 weeks, while the latter underwent simple local hyperthermia." | 2.73 | [Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms]. ( Sun, FL; Zang, T; Zhang, Y, 2008) |
| "Doxazosin was given for 30 days, and at the second visit IPSS, NIH-CPSI and IIEF-5 scores, Qmax and PMR were once more analysed." | 1.37 | Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. ( Aktas, A; Eryildirim, B; Faydaci, G; Kuyumcuoglu, U; Tarhan, F; Tuncer, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Asfuroglu, A | 1 |
| Balci, M | 1 |
| Aslan, Y | 1 |
| Senel, C | 1 |
| Guzel, O | 1 |
| Kilinckaya, MF | 1 |
| Turhan, T | 1 |
| Tuncel, A | 1 |
| Zhang, M | 1 |
| Li, H | 1 |
| Ji, Z | 1 |
| Dong, D | 1 |
| Yan, S | 1 |
| Zhang, Y | 1 |
| Sun, FL | 1 |
| Zang, T | 1 |
| Park, DS | 1 |
| Shim, JY | 1 |
| Faydaci, G | 1 |
| Kuyumcuoglu, U | 1 |
| Eryildirim, B | 1 |
| Aktas, A | 1 |
| Tarhan, F | 1 |
| Tuncer, M | 1 |
| Evliyaoğlu, Y | 1 |
| Burgut, R | 1 |
| Tuğcu, V | 1 |
| Taşçi, AI | 1 |
| Fazlioğlu, A | 1 |
| Gürbüz, G | 1 |
| Ozbek, E | 1 |
| Sahin, S | 1 |
| Kurtuluş, F | 1 |
| Cek, M | 1 |
| Kulovac, B | 1 |
| Aganović, D | 1 |
| Prcić, A | 1 |
| Hadziosmanović, O | 1 |
| Jeong, CW | 1 |
| Lim, DJ | 1 |
| Son, H | 1 |
| Lee, SE | 1 |
| Jeong, H | 1 |
6 trials available for doxazosin and Prostatitis
| Article | Year |
|---|---|
Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Chronic Pain; Doxazosin; Duloxetine Hydrochlor | 2017 |
[Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms].
Topics: Administration, Oral; Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Combined Mod | 2008 |
Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo.
Topics: Adrenergic alpha-Antagonists; Adult; Doxazosin; Humans; Male; Middle Aged; Pain; Pain Measurement; P | 2002 |
A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Doxazosin; | 2007 |
Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Doxazosin; Drug Therapy, Combination; | 2007 |
Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Doxazosin; Drug Therapy, Combination; Hu | 2008 |
3 other studies available for doxazosin and Prostatitis
| Article | Year |
|---|---|
What Is the Interaction between Urine C-Reactive Protein, Prostatic Inflammation, and Doxazosin Treatment in Patients with Benign Prostatic Hyperplasia? A Pilot Study.
Topics: Adrenergic alpha-Antagonists; Aged; C-Reactive Protein; Doxazosin; Humans; Inflammation; Male; Middl | 2022 |
Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antihypertensive A | 2008 |
Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Erectile Dysfunction; Humans; Male; Middle Aged; | 2011 |